glp 1 agonist vs bariatric surgery GLP1: WVU Medicine study | Nova Szoka MD, FACS, FASMBS posted on the topic Association between plausible genetic factors
Description
International Union of pharmacology
10.1038/s44220-025-00390-x 18 de PaivaI
The rapid expansion of this drug class since 2005 reflects growing recognition that managing blood sugar and body weight requires sophisticated, multi system approaches rather than single organ treatments
LEAN trial team
7% in the triple therapy arm ( p = 0.04)
Diabetes Obes Metab 2013;15:770773
